Welcome to Catalyst

Catalyst was built for the people who need it most: doctors, nurses, pharmacists, and their patients navigating Australia's alternative medicines landscape together. Since 2021, we've worked to make that journey simpler, more transparent, and more patient-centred.

On 1 July 2026, we moved Catalyst from a fully free platform to a Freemium model. We know that's the kind of change that deserves a clear explanation, so we want to be upfront about what's changed, what hasn't, and why.

Why Freemium, and what it means for you

Since we launched Catalyst in 2021, it's always been free. Free for HCPs and Free for patients.

That model gave us the independence to build something genuinely unbiased. But running without any revenue also meant real limitations on how quickly we could improve the platform, review and verify sections of supplier data more rigorously, and build features that make the HCPs' job easier and patients' experience better.

We've introduced paid product listings for Product Suppliers. Here's what that means in practice:

  1. You still pay nothing. Catalyst remains completely free for HCPs and patients. That's not changing.
  2. Rankings aren't for sale. Suppliers can't pay to move up in the rankings. Product rankings are still based on the same three criteria they've always been: clinical evidence, patient case studies, and data transparency.
  3. A two-tiered feed, not a two-tiered standard. The product feed is now split into Tier 1 (premium listings) and Tier 2 (free listings). Within each tier, the same ranking algorithm applies. Paid listings appear higher in the feed, but they earn their position within that tier through evidence quality and patient-centred data - not money.
  4. We have no financial interest in any product. honahlee is patient-owned and operated. We don't sell products, and we receive no financial benefit from the sale of any specific product. The only revenue we receive from suppliers is a flat platform listing fee.
  5. Paid listings fund the platform, not our pockets. Monetisation allows us to run more frequent data verification, develop new features, and make sure Catalyst stays accurate, up-to-date, and genuinely useful for HCPs and their patients.

We know that when money enters the picture, trust can be difficult to hold onto. We've worked hard to make sure that's not the case here. If you have questions or concerns about how this model works, we want to hear them.

Science and data - not sales

There are now over 1,600 products available to patients in Australia. Most of the education and product information still comes directly from the product suppliers themselves.

Did you know that multiple products on the market are the same product under different brands at different prices? And the most well-known active ingredients aren't the only chemicals that keep a product consistent from batch to batch.

Getting your education and product information from an independent source matters. While product suppliers have given us their product information, we present it without bias. Transparency is still the guiding principle behind Catalyst's product rankings, and that hasn't changed.

Up to date, patient centred information

In the current framework, some therapies are unregistered medicines. While they are not approved by the TGA, products must be consistent, and product suppliers should be focused on patient outcomes. Not only does the honahlee team reach out to suppliers, but suppliers also request to be listed on Catalyst so that you have everything you need to make better decisions in one place.

Product information

Product suppliers have been asked to provide detailed information about each product and to keep that information up to date from batch to batch. We check with suppliers on a regular basis to ensure their data is up to date.

Suppliers who are less transparent or aren't participating in patient-centred activities as much as other suppliers have their products ranked lower.

Product rankings

The suppliers who are more transparent about their products and are focused on better patient outcomes will rise in the product rankings. Because Catalyst was built to put patients' treatment first, the most important factors in our product rankings are:

  • Clinical research and studies directly related to a product
  • Patient case studies directly related to a product
  • Transparency from batch to batch

These variables were chosen because, in doing our research, both prescribers and suppliers have said these are the most important factors in making the best choices for patients.

To be clear, since product transparency has always been one of the major factors in our ranking algorithm, Premium listings with more visible information appear above others in the product feed.

Don't worry, when drilling down using the search bar OR by sorting, you'll get the best result for your search, not just a Premium result.

Your feedback in action

The Catalyst team consists of digital and technical experts with years of cannabis experience. In creating medical tech, we work closely with prescribers, industry partners and look to advanced markets for inspiration

Through our relationships with healthcare and industry experts, we've been able to create content and build tools that are making a real difference.

The unapproved medicines space is ever-evolving, and even the most experienced patient is constantly learning. Everything we've built has come from trust, collaboration and feedback. That includes the decision to move to Freemium. We welcome your honest thoughts on how it's working.

And from the honahlee team, thank you for your continued support and trust.